• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Pathog . Life course exposures continually shape antibody profiles and risk of seroconversion to influenza

tetano

Editor, Senior Moderator
PLoS Pathog


. 2020 Jul 23;16(7):e1008635.
doi: 10.1371/journal.ppat.1008635. eCollection 2020 Jul.
Life course exposures continually shape antibody profiles and risk of seroconversion to influenza


Bingyi Yang[SUP] 1 2 [/SUP], Justin Lessler[SUP] 3 [/SUP], Huachen Zhu[SUP] 4 5 [/SUP], Chao Qiang Jiang[SUP] 6 [/SUP], Jonathan M Read[SUP] 7 [/SUP], James A Hay[SUP] 8 [/SUP], Kin On Kwok[SUP] 9 10 11 [/SUP], Ruiyin Shen[SUP] 6 [/SUP], Yi Guan[SUP] 4 5 [/SUP], Steven Riley[SUP] 8 [/SUP], Derek A T Cummings[SUP] 1 2 [/SUP]



Affiliations
Free article

Abstract

Complex exposure histories and immune mediated interactions between influenza strains contribute to the life course of human immunity to influenza. Antibody profiles can be generated by characterizing immune responses to multiple antigenically variant strains, but how these profiles vary across individuals and determine future responses is unclear. We used hemagglutination inhibition titers from 21 H3N2 strains to construct 777 paired antibody profiles from people aged 2 to 86, and developed novel metrics to capture features of these profiles. Total antibody titer per potential influenza exposure increases in early life, then decreases in middle age. Increased titers to one or more strains were seen in 97.8% of participants during a roughly four-year interval, suggesting widespread influenza exposure. While titer changes were seen to all strains, recently circulating strains exhibited the greatest titer rise. Higher pre-existing, homologous titers at baseline reduced the risk of seroconversion to recent strains. After adjusting for homologous titer, we also found an increased frequency of seroconversion against recent strains among those with higher immunity to older previously exposed strains. Including immunity to previously exposures also improved the deviance explained by the models. Our results suggest that a comprehensive quantitative description of immunity encompassing past exposures could lead to improved correlates of risk of influenza infection.
 
Back
Top Bottom